Home›Companies›Biotech & Pharma›Aptamino

Aptamino, Inc.

Develops antibody drugs designed to be taken as pills by patients.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 6, 2026·Suggest an edit

About Aptamino

Aptamino is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $8,000,002 raised in one offering on Form D since April 2026. Its chief executive is Julie Zhang.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 17, 2026Apr 6, 2026$8,000,002fully sold7$1.1MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aptamino's Form D filed Apr 6, 2026.

Julie Zhang
Julie Zhang
Co-Founder, CEO and director
Isaac Lutz
Isaac Lutz
Co-Founder, CTO and director

Sources

  1. SECAptamino, Inc. filing history
  2. InvestorAptamino — Harpoon Ventures